NEW YORK (GenomeWeb) – MDxHealth announced today that it has partnered with the Andros Men's Health Clinic in the Netherlands to offer its SelectMDx liquid biopsy prostate cancer test to Andros' patients.

Under the terms of the deal, the clinic will offer the diagnostic to all patients considered at risk for prostate cancer, with over 500 patients to undergo testing in the first year of the partnership. SelectMDx will become available starting April 1.

Further terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.